No insider purchase over the last 90 days. The latest, by 赵宇翔, was filed 14 May 2026.
APT Medical Inc.: what insiders have been doing
Every trade that managers of APT Medical Inc. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 4 November 2026, 2 filings were filed, from 2 insiders.
Both sides are active: 1 purchase worth €299k and 1 sale worth €63.1M, from 1 insider and 1 insider respectively. Taken together, the sales exceed the purchases by €62.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 成正辉 filed the largest sale, €63.1M, on 20 October 2026. On the buying side, the filings list 1 board member among the declarants.
Across the 516 companies tracked on its exchange, the median is 2 filings; at 2 filings, this issuer sits right on that mark. Looking back to 2022, when coverage begins, insiders filed 2 purchases and 5 sales.
The most recent open-market purchase was published on 14 May 2026, 179 days ago.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +20.8%Entry CN¥234.21 · Close 03 Nov 2026 CN¥282.98
- +123.8%Entry CN¥77.47 · Close at T+365 CN¥173.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate APT Medical Inc. Strong Buy (bullish), based on 6 analysts. Average price target: CN¥352.74.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,122,937 shares@ CN¥1,667.160649.5% of flowA股XSHGSSE:273000001739340860
- 10,000 shares100.0% of flowA股XSHGSSE:273000000615639230Canonical exit: 12 Aug 2026 (T+90)
- 2,164,739 shares100.0% of flowA股XSHGSSE:173000009518584320
- 29,943 shares100.0% of flowA股XSHGSSE:173000008879613900
- 2,374 shares100.0% of flowA股XSHGSSE:173000007307411260
- 38,850 shares100.0% of flowA股XSHGSSE:173000006090861400
- 10,233 shares100.0% of flowA股XSHGSSE:173000005475364220Canonical exit: 26 Jul 2022 (T+90)
7 of 7 declarations
About APT Medical Inc.
惠泰医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
